Position in ELAN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$224,418
-$158,868 QoQ
Shares Held
9,119
-43.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#364
of 515 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Claret Asset Management Corp holds $30,317,140 across 7 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
685,523 | $28,127,008 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
204,108 | $1,006,252 | |
| 3 | ZTS |
Zoetis Inc.
|
3,526 | $253,378 | |
| 4 | VTRS |
Viatris Inc
|
15,214 | $241,598 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,425 | $240,169 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
9,119 | $224,418 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
414 | $224,317 |
All Filings in ELAN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $224,418 | 9,119 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $383,286 | 16,017 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $362,396 | 16,014 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $323,287 | 16,052 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $232,492 | 16,281 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $114,838 | 10,937 | Principal | Sole | 2025-05-13 | |
| 2024-12-31 | $132,350 | 10,929 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $159,430 | 10,853 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $155,786 | 10,796 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||